CSRxP: Eli Lilly’s Zepbound Announcement Leaves Prices High for Most Patients, Serves as Powerful Reminder Big Pharma Alone Sets Prices
Lowering Prices for Some Patients at Some Dosages Will Have Limited Impact,… Read More
Lowering Prices for Some Patients at Some Dosages Will Have Limited Impact,… Read More
Price Hikes and Egregious Prices on Blockbuster Drugs Boost Profits… Read More
Analysis Finds GLP-1 Blockbusters and “Multimillion-Dollar Gene Therapies”… Read More
Big Pharma Continues Raking in Expectation-Beating Profits and Revenue Fueled… Read More
More Brand Name Drug Makers Beat Wall Street Earnings After Hiking Prices This… Read More
Big Pharma Giants Top Wall Street Expectations After Hiking Prices on… Read More
Big Pharma Advertising Blitz Seeks to Protect Anti-Competitive Tactics That… Read More
Avik Roy Highlights How Increased USPTO-FDA Collaboration and Greater Scrutiny… Read More
Breaking Down the Facts on Drug Prices, Innovation, Patent Abuse… Read More
Research Article Explores Negative Implications of Proposal to Restrict Key… Read More
Research Column Explores Case Study in Common Patent Abuse Tactic That… Read More
Senate Judiciary Committee Puts Spotlight on Big Pharma’s Anti-Competitive… Read More